Cargando…

Biomarkers of systemic lupus erythematosus identified using mass spectrometry‐based proteomics: a systematic review

Advances in mass spectrometry technologies have created new opportunities for discovering novel protein biomarkers in systemic lupus erythematosus (SLE). We performed a systematic review of published reports on proteomic biomarkers identified in SLE patients using mass spectrometry‐based proteomics...

Descripción completa

Detalles Bibliográficos
Autores principales:	Nicolaou, Orthodoxia, Kousios, Andreas, Hadjisavvas, Andreas, Lauwerys, Bernard, Sokratous, Kleitos, Kyriacou, Kyriacos
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	John Wiley and Sons Inc. 2016
Materias:	Reviews
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5387176/ https://www.ncbi.nlm.nih.gov/pubmed/27878954 http://dx.doi.org/10.1111/jcmm.13031

Ejemplares similares

Proteomic analysis in lupus mice identifies Coronin-1A as a potential biomarker for lupus nephritis
por: Nicolaou, Orthodoxia, et al.
Publicado: (2020)

Alport syndrome: Proteomic analysis identifies early molecular pathway alterations in Col4a3 knock out mice
por: Nicolaou, Orthodoxia, et al.
Publicado: (2020)

Comparative analysis of affected and unaffected areas of systemic sclerosis skin biopsies by high-throughput proteomic approaches
por: Chairta, Paraskevi, et al.
Publicado: (2020)

High-Throughput Native Mass Spectrometry Screening in Drug Discovery
por: Gavriilidou, Agni F. M., et al.
Publicado: (2022)

Pharmacological Stimulation of Phagocytosis Enhances Amyloid Plaque Clearance; Evidence from a Transgenic Mouse Model of ATTR Neuropathy
por: Fella, Eleni, et al.
Publicado: (2017)

Omega-3 fatty acids supplementation protects the retina from age-associated degeneration in aged C57BL/6J mice
por: Prokopiou, Ekatherine, et al.
Publicado: (2019)

Systemic Evaluation of Chimeric LNA/2′-O-Methyl Steric Blockers for Myotonic Dystrophy Type 1 Therapy
por: Christou, Melina, et al.
Publicado: (2020)

ProtExA: A tool for post-processing proteomics data providing differential expression metrics, co-expression networks and functional analytics
por: Minadakis, George, et al.
Publicado: (2020)

Contributions of mass spectrometry-based proteomics to defining cellular mechanisms and diagnostic markers for systemic lupus erythematosus
por: Korte, Erik A, et al.
Publicado: (2012)

Intramuscular Evaluation of Chimeric Locked Nucleic Acid/2′OMethyl-Modified Antisense Oligonucleotides for Targeted Exon 23 Skipping in Mdx Mice
por: Georgiadou, Michaella, et al.
Publicado: (2021)

Mass spectrometry-based proteomics identify novel serum osteoarthritis biomarkers
por: Tardif, Ginette, et al.
Publicado: (2022)

Raman spectroscopy and mass spectrometry identifies a unique group of epidermal lipids in active discoid lupus erythematosus
por: Holtkamp, Hannah U, et al.
Publicado: (2023)

Serum GlycA Level Is Elevated in Active Systemic Lupus Erythematosus and Correlates to Disease Activity and Lupus Nephritis Severity
por: Dierckx, Tim, et al.
Publicado: (2020)

Tissue and plasma proteomic profiling indicates AHSG as a potential biomarker for ascending thoracic aortic aneurysms
por: Kazamia, Rafailia, et al.
Publicado: (2023)

Plasma proteomic analysis of systemic lupus erythematosus patients using liquid chromatography/tandem mass spectrometry with label-free quantification
por: Madda, Rashmi, et al.
Publicado: (2018)

Proteomic analysis identifies subgroups of patients with active systemic lupus erythematosus
por: Su, Kevin Y. C., et al.
Publicado: (2023)

Patient-derived podocyte spheroids reveal new insights into the etiopathogenesis of Alport syndrome
por: Romero-Guevara, Ricardo, et al.
Publicado: (2023)

Proteomics and Mass Spectrometry for Cancer Biomarker Discovery
por: Lu, Ming, et al.
Publicado: (2007)

Regulation of microRNA in systemic lupus erythematosus: the role of miR-21 and miR-210
por: Kourti, Maria, et al.
Publicado: (2020)

Combined proteomics and single cell RNA-sequencing analysis to identify biomarkers of disease diagnosis and disease exacerbation for systemic lupus erythematosus
por: Li, Yixi, et al.
Publicado: (2022)

Case definitions in Swedish register data to identify systemic lupus erythematosus
por: Arkema, Elizabeth V, et al.
Publicado: (2016)

The Role of Clinical Features and Serum Biomarkers in Identifying Patients with Incomplete Lupus Erythematosus at Higher Risk of Transitioning to Systemic Lupus Erythematosus: Current Perspectives
por: Sternhagen, Erin, et al.
Publicado: (2022)

Biomarkers in Alzheimer’s Disease Analysis by Mass Spectrometry-Based Proteomics
por: Liu, Yahui, et al.
Publicado: (2014)

Mass spectrometry‐based tear proteomics for noninvasive biomarker discovery
por: Ponzini, Erika, et al.
Publicado: (2021)

Enrichment of Complement, Immunoglobulins, and Autoantibody Targets in the Proteome of Platelets from Patients with Systemic Lupus Erythematosus
por: Linge, Carl Petrus, et al.
Publicado: (2022)

Proteomics Methodologies: The Search of Protein Biomarkers Using Microfluidic Systems Coupled to Mass Spectrometry
por: De Figueiredo, Isabel, et al.
Publicado: (2023)

Proteomic analyses reveal cystatin c is a promising biomarker for evaluation of systemic lupus erythematosus
por: Huang, He, et al.
Publicado: (2023)

The BRCA1 Variant p.Ser36Tyr Abrogates BRCA1 Protein Function and Potentially Confers a Moderate Risk of Breast Cancer
por: Christou, Charita M., et al.
Publicado: (2014)

Combination of a 15-SNP Polygenic Risk Score and Classical Risk Factors for the Prediction of Breast Cancer Risk in Cypriot Women
por: Yiangou, Kristia, et al.
Publicado: (2021)

Improved prognostic diagnosis of systemic lupus erythematosus in an early stage of disease by a combination of different predictive biomarkers identified by proteome analysis
por: Boenisch, Maximilian, et al.
Publicado: (2014)

Metabolic Analysis of Potential Key Genes Associated with Systemic Lupus Erythematosus Using Liquid Chromatography-Mass Spectrometry
por: Zeng, Li, et al.
Publicado: (2021)

Epigenetic Aspects of Systemic Lupus Erythematosus
por: Relle, Manfred, et al.
Publicado: (2015)

Cell Surface Proteome of Dental Pulp Stem Cells Identified by Label-Free Mass Spectrometry
por: Niehage, Christian, et al.
Publicado: (2016)

Extracellular Vesicles as Biomarkers of Systemic Lupus Erythematosus
por: Perez-Hernandez, Javier, et al.
Publicado: (2015)

Clinical and Immunological Biomarkers for Systemic Lupus Erythematosus
por: Yu, Haitao, et al.
Publicado: (2021)

Complement as a Biomarker for Systemic Lupus Erythematosus
por: Ayano, Masahiro, et al.
Publicado: (2023)

Relative validity and reproducibility of the CyFFQ semiquantitative food frequency questionnaire for assessing dietary intake in Cypriot adults
por: Philippou, Elena, et al.
Publicado: (2022)

Application of mass spectrometry-based proteomics for biomarker discovery in neurological disorders
por: Venugopal, Abhilash, et al.
Publicado: (2009)

Proteomics Approach for the Discovery of Rheumatoid Arthritis Biomarkers Using Mass Spectrometry
por: Mun, Sora, et al.
Publicado: (2019)

Quantitative Mass Spectrometry-Based Proteomics for Biomarker Development in Ovarian Cancer
por: Ryu, Joohyun, et al.
Publicado: (2021)

Cannot write session to /tmp/vufind_sessions/sess_04qp7qa17mh5qk2afo2f1lmg63